These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37981276)

  • 21. Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay.
    Qu L; Zhang X; Wang J; Zhou H; Hou T; Wei L; Xu F; Liang X
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):937-950. PubMed ID: 31781785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective.
    Boss C; Bolli MH; Gatfield J
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3381-94. PubMed ID: 27321813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
    Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML
    FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: interaction in the recognition of endothelin-1 between ETA and ETB receptors.
    Himeno A; Shigematsu K; Taguchi T; Niwa M
    Cell Mol Neurobiol; 1998 Aug; 18(4):447-52. PubMed ID: 9619300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin ET
    Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin B receptor-mediated regulation of endothelin-1 content and release in cultured porcine aorta endothelial cell.
    Sanchez R; MacKenzie A; Farhat N; Nguyen TD; Stewart DJ; Mercier I; Calderone A; Thorin E
    J Cardiovasc Pharmacol; 2002 May; 39(5):652-9. PubMed ID: 11973408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase.
    Briançon-Marjollet A; Monneret D; Henri M; Hazane-Puch F; Pepin JL; Faure P; Godin-Ribuot D
    J Physiol; 2016 Mar; 594(6):1727-40. PubMed ID: 26663321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.
    Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T
    Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
    Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
    Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.
    Talbodec A; Berkane N; Blandin V; Breittmayer JP; Ferrari E; Frelin C; Vigne P
    Mol Pharmacol; 2000 Apr; 57(4):797-804. PubMed ID: 10727528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane dynamics simulation and virtual screening reveals potential dual natural inhibitors of endothelin receptors for targeting glaucomatous condition.
    Nagarajan H; Vetrivel U
    Life Sci; 2021 Mar; 269():119082. PubMed ID: 33482184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin receptors and their antagonists.
    Maguire JJ; Davenport AP
    Semin Nephrol; 2015 Mar; 35(2):125-36. PubMed ID: 25966344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High affinity interaction of endothelin-3 with recombinant ETA receptors.
    Desmarets J; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(2):357-60. PubMed ID: 10079188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of immobilized beta1-adrenoceptor chromatography for rapid discovery of ligands specifically binding to the receptor from herbal extract.
    Shayiranbieke A; Liang Q; Wang T; Ma J; Li G; Du X; Zhang G; Wang C; Zhao X
    J Chromatogr A; 2022 Aug; 1677():463298. PubMed ID: 35809523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
    Seo B; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
    Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
    PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: a model of mispatterning of the branchial arch derivatives.
    Kempf H; Linares C; Corvol P; Gasc JM
    Development; 1998 Dec; 125(24):4931-41. PubMed ID: 9811577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LU 302 872 and its racemate (LU 224 332) show balanced endothelin-A/B receptor affinity, high oral activity, and inhibit human prostate tissue contractions.
    Raschack M; Göck S; Unger L; Hahn A; Amberg W; Jansen R; Alken P; Weber A; Hergenröder S
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S241-4. PubMed ID: 9595449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
    Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.